Full Text View
Tabular View
Study Results
Related Studies
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
This study has been terminated.
( See termination reason in detailed description. )
Study NCT00356421   Information provided by Pfizer
First Received: July 24, 2006   Last Updated: August 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 1
Additional conditions recognized in this trial
Diabetes Mellitus
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
Inhaled Human Insulin (Exubera®)
Insulin lispro (Humalog)
Additional drug interventions recognized in this trial
Glargine
Insulin
Insulin LISPRO
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services